Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchgrowth hormonepediatricsshort staturemeta-analysis

Meta-analysis compares weekly and daily growth hormone in short stature

Frontiers in Endocrinology review pools trials of long-acting versus daily growth hormone in children, assessing quality of life, efficacy and safety.

PR
By Priya Raman · Science Reporter
Sep 1 20:00 ETSource: Frontiers in endocrinology

The wire

  1. 01Liu and colleagues published a systematic review and meta-analysis of weekly long-acting versus daily growth hormone therapy in children with short stature.
  2. 02Long-acting peptide formulations aim to reduce injection burden in pediatric endocrinology.
  3. 03Pooled effect sizes and conclusions are not detailed in the excerpt.

From the source

Weekly long-acting growth hormone versus daily growth hormone therapy on quality of life, efficacy, and safety in children with short stature: a systematic review and meta-analysis

Frontiers in endocrinology · 2026 · Liu F, Xiu L, Zhang W et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42751562/